**Chapter 8**

*Dengue Fever in a One Health Perspective*

10.1016/j.celrep.2018.12.065

[77] Wu Y, Li S, Du L, et al. Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III. Emerging Microbes & Infections. 2017;**6**:e89. DOI:

[78] Mwale PF, Lee CH, Lin LT et al. Expression, purification, and characterization of anti-Zika virus envelope protein: Polyclonal and chicken-derived single chain variable fragment antibodies. International Journal of Molecular Sciences. 2020;**21**(2). pii: E492. DOI: 10.3390/

[79] Moreland NJ, Tay MY, Lim E, et al. High affinity human antibody fragments to dengue virus nonstructural protein 3. PLoS Neglected Tropical Diseases. 2010;**4**:e881. DOI: 10.1371/journal.pntd.0000881

[80] Poungpair O, Bangphoomi K, Chaowalit P, et al. Generation of human single-chain variable fragment antibodies specific to dengue virus non-structural protein 1 that interfere with the virus infectious cycle. MAbs. 2014;**6**:474-482. DOI: 10.4161/

10.1038/emi.2017.79

ijms21020492

mabs.27874

[76] Lu X, Xiao H, Li S, et al. Double lock of a human neutralizing and protective monoclonal antibody targeting the yellow fever virus envelope. Cell Reports. 2019;**26**(2):438-446.e5. DOI:

**166**
